British Journal of Oral and Maxillofacial Surgery
Volume 46, Issue 6 , Pages 435-438 , September 2008

Effect of using RNA interference to alter iNOS gene expression on the proliferation of tongue squamous cell carcinoma cell line Tca8113

  • Wei-liang Chen

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, P. R. China
    • Corresponding Author InformationCorresponding author. Department of Oral and Maxillofacial Surgery, Second Affiliated Hospital of Sun Yat-Sen University, 107 Yanjiang Road, Guangzhou 510120, P. R. China.
  • ,
  • Lan Yang

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital, Guangzhou Medical College, Guangzhou, Guangdong 510120, P. R. China
  • ,
  • Shu-guang Zeng

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Guangdong Provincial Stomatologic Hospital/the Affiliated Stomatoligic Hospital of South Medical University, Guangzhou, Guangdong 510280, P. R. China
  • ,
  • Yong-jie Wang

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the Second Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, P. R. China

,Accepted 16 February 2008.

References 

  1. Thippeswamy T, McKay JS, Quinn JP, Morris R. Nitric oxide, a biological double-faced janus–is this good or bad?. Histol Histopathol. 2006;21:445–448
  2. Williams EL, Djamgoz MB. Nitric oxide and metastatic cell behaviour. Bioessays. 2005;27:1228–1238
  3. Rao CV. Nitric oxide signaling in colon cancer chemoprevention. Mutat Res. 2004;555:107–119
  4. Reveneau S, Amould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest. 1999;79:1215–1225
  5. Chen WL, Zeng SG, Li HG, Huang HZ, Pan CB. Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue. Ai Zheng. 2002;21:314–318
  6. Fujimoto H, Ando Y, Yamashita T, Terazaki H, Sasaki J, Matsumoto M, et al. Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res. 1997;88:1190–1198
  7. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst. 1998;90:587–596
  8. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;319:806–811
  9. Matzke M, Matzke AJ, Kooter JM. RNA: guiding gene silencing. Science. 2001;293:1080–1083
  10. Pronai L, Szaleczky E, Feher J. Nitric oxide. Basic research and possible clinical use. Orv Hetil. 1996;137:1699–1704
  11. Yatabe Y, Masuda A, Koshikawa T, Nakamura S, Kuroishi T, Osada H, et al. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res. 1998;58:1042–1047
  12. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995;93:17–48
  13. Son K, Kwon C. Stabilization of human epidermal growth factor (hEGF) in aqueous formulation. Pharm Res. 1995;12:451–454
  14. Brune B, Messmer UK, Sandau K. The role of nitric oxide in cell injury. Toxicol Lett. 1995;82–83:233–237
  15. Tamir S, Tannenbaum SR. The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta. 1996;1288:F31–F36
  16. Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, et al. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma. Jpn J Cancer Res. 1998;89:696–702
  17. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001;2:149–156
  18. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem. 1997;272:1402–1411
  19. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest. 1995;95:1884–1890

PII: S0266-4356(08)00059-4

doi: 10.1016/j.bjoms.2008.02.009

British Journal of Oral and Maxillofacial Surgery
Volume 46, Issue 6 , Pages 435-438 , September 2008